IMNMImmunome, Inc.

$26.80

What is the market doing?

What the tape says about IMNM

Immunome, Inc. is +161% over the past year while the S&P 500 is +20%: 141 points ahead of the market.

+161%

1-year return · S&P 500 +20%

vs 200-day average
+22%

vs 200-day average · a clear uptrend

RSI (14)
47

RSI (14) · neutral

Below its 52-week high
10%

Below its 52-week high

2024-08-15$5.56 – $29.84 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$26.80
1 monthS&P 500 −0.30%
+3.6%
1 yearS&P 500 +20%
+161%
5 yearsS&P 500 +85%
+91%
vs 50-day average$23.88
+12%
52-week high
$29.84
52-week low
$8.99
Annualised volatility
72%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$587K
Calendar-year price return
YearReturn
2026 (year to date)+25%
2025+102%
2024−0.75%
2023+384%
2022−83%
2021+34%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan65 of 6+39%
Feb62 of 6+25%
Mar63 of 6−7.5%
Apr62 of 6−11%
May63 of 6−1.2%
Jun62 of 6−1.3%
Jul64 of 6+11%
Aug62 of 6+5.2%
Sep63 of 6+16%
Oct52 of 5+3.1%
Nov62 of 6−0.62%
Dec62 of 6−9.3%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.